$RYM

Holtzman Max sold $130K of RYM

Holtzman Max sold 5,000 shares of RYTHM, Inc. (RYM) at an average of $26.00 ($25.49–$27.39, $0.13M total) across 3 trades on 2026-06-16.

Original reporting
SEC EDGAR · Holtzman Max
Published Jun 18, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 11:56 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$RYM
Neutral
medium confidence
Mentioned
$RYM
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RYMNeutralLow
01

Why it matters

The only new information is the director’s open-market sale details and the absence of a disclosed 10b5-1 plan in the filing summary.

02

Market read

Traders may monitor for follow-on insider activity, but there is no accompanying operational or financial catalyst in the text.

03

What to watch

The filing does not state motives, whether other insiders sold/bought, or whether there is a broader pattern of insider activity around the same period.

Relevance 4/10Novelty 3/10Timing: filed 2026-06-18, covering sales dated 2026-06-16

Background

The article is an SEC Form 4 insider transaction disclosure for RYTHM, Inc. (RYM).

Company-level read

Ticker impact

$RYMNeutralMedium confidence
Context

SEC Form 4 shows director Holtzman Max sold about 5,000 shares of RYTHM at $25.49 to $27.39 across three trades.

Expected impact

Likely limited, short-lived sentiment impact; no clear directional signal from a single sale without additional context.

Evidence & confidence

The filing is primary-source and time-stamped, but the article provides only the sale details (size, price range) and no accompanying company news, guidance, or legal/regulatory event.

Market effects

No sector read-through is provided beyond routine insider trading activity.

None indicated.

None indicated.

Counterpoint

Insider sales can be routine liquidity management and may not reflect negative fundamentals, especially when the sale size is small relative to typical institutional float.

Key entities

  • RYTHM, Inc.

    Company whose shares were sold by a director, disclosed via SEC Form 4.

  • Holtzman Max

    Director who executed the reported open-market sale transactions.

Related articles

$RYMMed

RYTHM, Inc. (RYM): Results of Operations and Financial Condition

RYTHM, Inc. (RYM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ea029949501ex99-1.htm PRESS RELEASE OF RYTHM, INC. DATED AUGUST 4, 2026 Exhibit 99.1 RYTHM, Inc. Reports Second Quarter 2026 Results ROLLING MEADOWS, IL, August 4, 2026 (GLOBE NEWSWIRE) – RYTHM, Inc. (Nasdaq: RYM) (“RYTHM” or the “Company”), America’s THC Company whose

$RYMMedAI 8/10

Daily NZX update, Friday, June 5, 2026

NZX 50 was up 0.3% at 3:00pm, though down 0.5% over five days and 2.6% over six months. Top gainers included Air New Zealand (+2%), Mainfreight (+2%) and Genesis Energy (+2%); biggest fallers were Kathmandu (-3%), A2 Milk (-2%) and Tourism Holdings (-2%). SmartShares ETFs were mixed. Meridian welcomed a draft Fast-track Panel decision on Lake Pūkaki access; Infratil completed a $200m capital bond offer; Ryman reported FY26 EBITDAF $88.3m and free cash flow $188.3m.

$RYMMedAI 8/10

Daily NZX update, Wednesday, June 3, 2026

NZX50 was down 0.3% at 3:00pm, though up 0.4% over five sessions and 6.5% over 12 months. Gentrack Group led gainers (+4%), while Vista Group fell the most (-3%). Ebos (-3%) and A2 Milk (-1%) also declined. Ryman Healthcare is considering new six-year secured bonds; Scales Corp declared a 12.5c FY2025 final dividend; Pacific Edge raised NZ$36.1m at NZ$0.17/share.